Abstract
This is the first article of a four-part update series on “nuclear medicine updates.” Upon completion of this article, the reader will understand (1) the use of indium-labeled antibodies in the detection of cancer and other disease states; (2) nontumor radioimmunoscintigraphy with indium; and (3) quality control procedures for indium-labeled antibodies.